Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy-Reference-Cited by-同舟云学术

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy

Published:2015-05 Issue:5 Volume:72 Page:780-785.e3
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gerami Pedram,Cook Robert W.,Russell Maria C.,Wilkinson Jeff,Amaria Rodabe N.,Gonzalez Rene,Lyle Stephen,Jackson Gilchrist L.,Greisinger Anthony J.,Johnson Clare E.,Oelschlager Kristen M.,Stone John F.,Maetzold Derek J.,Ferris Laura K.,Wayne Jeffrey D.,Cooper Chelsea,Obregon Roxana,Delman Keith A.,Lawson David

Publisher

Elsevier BV

Subject

Dermatology

Reference17 articles.

1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

2. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma;Gerami;J Mol Diagn,2011

3. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma;Onken;Ophthalmology,2012

4. The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma;Harbour;PLoS Curr,2013

5. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy;European Journal of Cancer;2024-05

2. Sentinel Lymph Node Biopsy Calculators for Informed Decision-Making;JAMA Surgery;2024-03-01

3. The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment;Cancers;2024-01-30

4. The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma;Cancers;2024-01-09

5. Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?;Clinical & Experimental Metastasis;2023-12-08